Historical record - last NADAC effective date: 8/22/2018
Product Information
PLAQUENIL 200 MG TABLET is a brand product labeled by Advanz Pharma (US) Corp., priced at $9.1099 per EA under NDC 59212056210. Its NADAC has been published 140 times since Apr 13, 2016.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Hydroxychloroquine Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Advanz Pharma (US) Corp.NDC
59212056210
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/22/2018
Active Ingredients
HYDROXYCHLOROQUINE SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA009768FDA Approved
Before 1982
TE Code
AB
On Market Since
6/28/2013
Pharmacological Classes
Price Statistics
The NADAC for PLAQUENIL 200 MG TABLET has been published 140 times since Apr 13, 2016, and over the history we have for it it has risen 49.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.1099 per EA |
|---|---|
| All-time high | $9.2149 (Jul 11, 2018) |
| All-time low | $6.1144 (Apr 13, 2016) |
| Median price | $9.1099 |
| Average price | $8.3462 |
| Largest weekly change | +21.2% (Oct 19, 2016) |
| Weeks tracked | 140 |
| Tracking since | Apr 13, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+49.0%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PLAQUENIL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PLAQUENIL 200 MG TABLET, manufactured by Advanz Pharma (US) Corp., is $9.1099 per EA (NDC 59212056210), effective Jan 16, 2019.
How has the price of PLAQUENIL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for PLAQUENIL 200 MG TABLET has risen 49.0%. It has been tracked across 140 weekly CMS publications since Apr 13, 2016.
What are the highest and lowest recorded NADAC prices for PLAQUENIL 200 MG TABLET?
Since Apr 13, 2016, the NADAC for PLAQUENIL 200 MG TABLET has ranged from a low of $6.1144 (Apr 13, 2016) to a high of $9.2149 (Jul 11, 2018), with a median of $9.1099 per EA.
Are there cheaper alternatives to PLAQUENIL 200 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROXYCHLOROQUINE 200 MG TAB, is $0.1485 per EA — about 98% below PLAQUENIL 200 MG TABLET.
Who manufactures PLAQUENIL 200 MG TABLET?
PLAQUENIL 200 MG TABLET (NDC 59212056210) is labeled by Advanz Pharma (US) Corp., and CMS classifies it as a brand product.